Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1993 Mar;91(3):1247–1252. doi: 10.1172/JCI116288

Carnitine-acylcarnitine translocase deficiency with severe hypoglycemia and auriculo ventricular block. Translocase assay in permeabilized fibroblasts.

S V Pande 1, M Brivet 1, A Slama 1, F Demaugre 1, C Aufrant 1, J M Saudubray 1
PMCID: PMC288085  PMID: 8450053

Abstract

Deficiency of the enzymes of mitochondrial fatty acid oxidation and related carnitine dependent steps have been shown to be one of the causes of the fasting-induced hypoketotic hypoglycemia. We describe here carnitine-acylcarnitine translocase deficiency in a neonate who died eight days after birth. The proband showed severe fasting-induced hypoketotic hypoglycemia, high plasma creatine kinase, heartbeat disorder, hypothermia, and hyperammonemia. The plasma-free carnitine on day three was only 3 microM, and 92% of the total carnitine (37 microM) was present as acylcarnitine. Treatments with intravenous glucose, carnitine, and medium-chain triglycerides had been tried without improvements. Measurements in fibroblasts confirmed deficient oxidation of palmitate and showed normal activities of the carnitine palmitoyltransferases I and II and of the three acyl-CoA dehydrogenases. A total deficiency of the carnitine-acyl-carnitine translocase was found in fibroblasts using the carnitine acetylation assay (1986. Biochem. J. 236:143-148). This assay has been further simplified by seeking conditions permitting application to permeabilized fibroblasts and lymphocytes.

Full text

PDF
1247

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bougneres P. F., Saudubray J. M., Marsac C., Bernard O., Odievre M., Girard J. R. Decreased ketogenesis due to deficiency of hepatic carnitine acyl transferase. N Engl J Med. 1980 Jan 10;302(2):123–124. [PubMed] [Google Scholar]
  2. Chapoy P. R., Angelini C., Brown W. J., Stiff J. E., Shug A. L., Cederbaum S. D. Systemic carnitine deficiency--a treatable inherited lipid-storage disease presenting as Reye's syndrome. N Engl J Med. 1980 Dec 11;303(24):1389–1394. doi: 10.1056/NEJM198012113032403. [DOI] [PubMed] [Google Scholar]
  3. Corr P. B., Creer M. H., Yamada K. A., Saffitz J. E., Sobel B. E. Prophylaxis of early ventricular fibrillation by inhibition of acylcarnitine accumulation. J Clin Invest. 1989 Mar;83(3):927–936. doi: 10.1172/JCI113978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Demaugre F., Bonnefont J. P., Colonna M., Cepanec C., Leroux J. P., Saudubray J. M. Infantile form of carnitine palmitoyltransferase II deficiency with hepatomuscular symptoms and sudden death. Physiopathological approach to carnitine palmitoyltransferase II deficiencies. J Clin Invest. 1991 Mar;87(3):859–864. doi: 10.1172/JCI115090. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. DiMauro S., DiMauro P. M. Muscle carnitine palmityltransferase deficiency and myoglobinuria. Science. 1973 Nov 20;182(4115):929–931. doi: 10.1126/science.182.4115.929. [DOI] [PubMed] [Google Scholar]
  6. Felig P., Wahren J. Fuel homeostasis in exercise. N Engl J Med. 1975 Nov 20;293(21):1078–1084. doi: 10.1056/NEJM197511202932107. [DOI] [PubMed] [Google Scholar]
  7. Frerman F. E., Goodman S. I. Deficiency of electron transfer flavoprotein or electron transfer flavoprotein:ubiquinone oxidoreductase in glutaric acidemia type II fibroblasts. Proc Natl Acad Sci U S A. 1985 Jul;82(13):4517–4520. doi: 10.1073/pnas.82.13.4517. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hale D. E., Batshaw M. L., Coates P. M., Frerman F. E., Goodman S. I., Singh I., Stanley C. A. Long-chain acyl coenzyme A dehydrogenase deficiency: an inherited cause of nonketotic hypoglycemia. Pediatr Res. 1985 Jul;19(7):666–671. doi: 10.1203/00006450-198507000-00006. [DOI] [PubMed] [Google Scholar]
  9. Hale D. E., Thorpe C., Braat K., Wright J. H., Roe C. R., Coates P. M., Hashimoto T., Glasgow A. M. The L-3-hydroxyacyl-CoA dehydrogenase deficiency. Prog Clin Biol Res. 1990;321:503–510. [PubMed] [Google Scholar]
  10. Indiveri C., Tonazzi A., Palmieri F. Identification and purification of the carnitine carrier from rat liver mitochondria. Biochim Biophys Acta. 1990 Oct 24;1020(1):81–86. doi: 10.1016/0005-2728(90)90096-m. [DOI] [PubMed] [Google Scholar]
  11. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  12. Lemons R., Forster S., Thoene J. Protein microinjection by protease permeabilization of fibroblasts. Anal Biochem. 1988 Jul;172(1):219–227. doi: 10.1016/0003-2697(88)90435-6. [DOI] [PubMed] [Google Scholar]
  13. McGarry J. D., Foster D. W. Regulation of hepatic fatty acid oxidation and ketone body production. Annu Rev Biochem. 1980;49:395–420. doi: 10.1146/annurev.bi.49.070180.002143. [DOI] [PubMed] [Google Scholar]
  14. Moon A., Rhead W. J. Complementation analysis of fatty acid oxidation disorders. J Clin Invest. 1987 Jan;79(1):59–64. doi: 10.1172/JCI112808. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Murthy M. S., Kamanna V. S., Pande S. V. A carnitine/acylcarnitine translocase assay applicable to biopsied muscle specimens without requiring mitochondrial isolation. Biochem J. 1986 May 15;236(1):143–148. doi: 10.1042/bj2360143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Pande S. V. A mitochondrial carnitine acylcarnitine translocase system. Proc Natl Acad Sci U S A. 1975 Mar;72(3):883–887. doi: 10.1073/pnas.72.3.883. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Pande S. V., Parvin R. Carnitine-acylcarnitine translocase catalyzes an equilibrating unidirectional transport as well. J Biol Chem. 1980 Apr 10;255(7):2994–3001. [PubMed] [Google Scholar]
  18. Parvin R., Goswami T., Pande S. V. Inhibition of mitochondrial carnitine-acylcarnitine translocase by sulfobetaines. Can J Biochem. 1980 Oct;58(10):822–830. doi: 10.1139/o80-115. [DOI] [PubMed] [Google Scholar]
  19. Roe C. R., Millington D. S., Norwood D. L., Kodo N., Sprecher H., Mohammed B. S., Nada M., Schulz H., McVie R. 2,4-Dienoyl-coenzyme A reductase deficiency: a possible new disorder of fatty acid oxidation. J Clin Invest. 1990 May;85(5):1703–1707. doi: 10.1172/JCI114624. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Saudubray J. M., Coudé F. X., Demaugre F., Johnson C., Gibson K. M., Nyhan W. L. Oxidation of fatty acids in cultured fibroblasts: a model system for the detection and study of defects in oxidation. Pediatr Res. 1982 Oct;16(10):877–881. doi: 10.1203/00006450-198210000-00015. [DOI] [PubMed] [Google Scholar]
  21. Saudubray J. M., Mitchell G., Bonnefont J. P., Schwartz G., Nuttin C., Munnich A., Brivet M., Vassault A., Demaugre F., Rabier D. Approach to the patient with a fatty acid oxidation disorder. Prog Clin Biol Res. 1992;375:271–288. [PubMed] [Google Scholar]
  22. Stanley C. A., Hale D. E., Berry G. T., Deleeuw S., Boxer J., Bonnefont J. P. Brief report: a deficiency of carnitine-acylcarnitine translocase in the inner mitochondrial membrane. N Engl J Med. 1992 Jul 2;327(1):19–23. doi: 10.1056/NEJM199207023270104. [DOI] [PubMed] [Google Scholar]
  23. Treem W. R., Stanley C. A., Finegold D. N., Hale D. E., Coates P. M. Primary carnitine deficiency due to a failure of carnitine transport in kidney, muscle, and fibroblasts. N Engl J Med. 1988 Nov 17;319(20):1331–1336. doi: 10.1056/NEJM198811173192006. [DOI] [PubMed] [Google Scholar]
  24. Trevisan C. P., Reichmann H., DeVivo D. C., DiMauro S. Beta-oxidation enzymes in normal human muscle and in muscle from a patient with an unusual form of myopathic carnitine deficiency. Muscle Nerve. 1985 Oct;8(8):672–675. doi: 10.1002/mus.880080809. [DOI] [PubMed] [Google Scholar]
  25. Wisneski J. A., Gertz E. W., Neese R. A., Mayr M. Myocardial metabolism of free fatty acids. Studies with 14C-labeled substrates in humans. J Clin Invest. 1987 Feb;79(2):359–366. doi: 10.1172/JCI112820. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES